[1]
“Development And Toxicological Evolution Of Pegylated Chitosan Nanoparticle For The Simultaneous Delivery Of Silymarin And Dehydroemetine For The Enhance Hepatic Targeting”, Journal of Pharmaceutical Negative Results, pp. 4732–4739, Feb. 2023, doi: 10.47750/pnr.2022.13.S08.617.